Filing Details
- Accession Number:
- 0001209191-21-022613
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-23 17:33:48
- Reporting Period:
- 2021-03-19
- Accepted Time:
- 2021-03-23 17:33:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1000694 | Novavax Inc | NVAX | Biological Products, (No Disgnostic Substances) (2836) | 222816046 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1051997 | Jr A Michael Mcmanus | C/O Novavax, Inc. 21 Firstfield Road Gaithersburg MD 20878 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-03-19 | 1,000 | $221.40 | 8,951 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-19 | 3,000 | $220.57 | 5,951 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Billionaire Hedge Funds
